KangMYangAHannafordP, et al.Skin necrosis following sclerotherapy. Part 1: differential diagnosis based on classification of pathogenic mechanisms. Phlebology2022; 37: 409–424.
2.
KangMYangAHannafordP, et al.Skin necrosis following sclerotherapy. Part 2: risk minimisation and management strategies. Phlebology2022; 37: 628–643.
3.
StaubesandJSeydewitzV. Ultrastructural changes following paravascular and intra-arterial injection of sclerosing agents: an experimental contribution to the problem of iatrogenic damage. Phlebologie1991; 20: 1–8.
4.
StaubesandJCheonM-J. Spätschäden an peripheren Nerven durch Paravasate von Polidocanol - eine elektronen- mikroskopische Studie. Phlebologie1994; 23: 112–119.
5.
ZipperSG. Nervus peroneus-Schaden nach Varizen Sklerosierung mit Aethoxysklerol. Versicherungsmedizin2000; 4: 185–187.
6.
GoorW. Personal communication, 1992.
7.
HansenHH. Experimentelle Untersuchungen zur Wirkung sklerosierender Lösung bei der paravasalen Verödungsbehandlung. Langenbecks Arch Chir1979; 348: 201–209.
8.
Schuller-PetrovicSPavlovicMD, et al.Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy. J Eur Acad Dermatol Venereol2011; 25: 983–986.
9.
SchiblerFBorradoriLRameletAA. Subcutaneous injection of large volumes of polidocanol. Dermatol Surg2019; 45: 476–477.
10.
TranDParsiK. Veno-arteriolar reflex vasospasm of small saphenous artery complicating sclerotherapy of the small saphenous vein. Austral NZ J Phleb2007; 10: 29–32.
